Silexion Therapeutics Ltd. (SLXN) Options Chain

The options chain displays all available contracts with real-time quotes, Greeks, volume, and open interest for each strike and expiration. It is the primary tool for options trade selection.

Silexion Therapeutics Ltd. (SLXN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.1M, listed on NASDAQ, employing roughly 14 people, carrying a beta of -0.26 to the broader market. Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. Led by Ilan Hadar, public since 2024-08-16.

The options chain displays all available contracts with quotes, Greeks, and open interest. No recent options activity for SLXN as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how the options chain is reported and how to read the data →